TransMedics Group, Inc. logo

TransMedics Group, Inc.

NASDAQ:TMDX

Overview | Financials
Company Name TransMedics Group, Inc.
Symbol TMDX
Currency USD
Price 61.02
Market Cap 2,047,922,730
Dividend Yield 0%
52-week-range 59.722 - 177.37
Industry Medical Devices
Sector Healthcare
CEO Dr. Waleed H. Hassanein M.D.
Website https://www.transmedics.com

An error occurred while fetching data.

About TransMedics Group, Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic

Related Stocks

Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc.

KYMR

40.11 USD

Health Catalyst, Inc. logo

Health Catalyst, Inc.

HCAT

7.08 USD

AngioDynamics, Inc. logo

AngioDynamics, Inc.

ANGO

8.91 USD

Alphatec Holdings, Inc. logo

Alphatec Holdings, Inc.

ATEC

9.19 USD

Cue Health Inc. logo

Cue Health Inc.

HLTH

0.043 USD

NanoString Technologies, Inc. logo

NanoString Technologies, Inc.

NSTG

0.105 USD

Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc.

ORGO

3.19 USD

ImmunoGen, Inc. logo

ImmunoGen, Inc.

IMGN

31.235 USD

Alector, Inc. logo

Alector, Inc.

ALEC

1.78 USD

Financials

Numbers are in millions USD

Numbers are in millions USD